PROTOPAM Drug Patent Profile
✉ Email this page to a colleague
When do Protopam patents expire, and what generic alternatives are available?
Protopam is a drug marketed by Baxter Hlthcare Corp and Wyeth Ayerst and is included in two NDAs.
The generic ingredient in PROTOPAM is pralidoxime chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralidoxime chloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROTOPAM?
- What are the global sales for PROTOPAM?
- What is Average Wholesale Price for PROTOPAM?
Summary for PROTOPAM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Drug Prices: | Drug price information for PROTOPAM |
| DailyMed Link: | PROTOPAM at DailyMed |
US Patents and Regulatory Information for PROTOPAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | PROTOPAM CHLORIDE | pralidoxime chloride | INJECTABLE;INJECTION | 014134-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wyeth Ayerst | PROTOPAM CHLORIDE | pralidoxime chloride | TABLET;ORAL | 014122-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
